Stock Returns of Pharmaceutical Companies during COVID-19

IF 1.1 4区医学 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Ajar-African Journal of Aids Research Pub Date : 2023-09-01 DOI:10.35129/ajar.v6i02.384

Ajeng Aprilyana Pratiwi, Diyah Santi Hariyani, Wenni Wahyuandari, Eni Minarni

引用次数: 0

Abstract

The Covid-19 pandemic has had a major impact on the share prices of companies in Indonesia, while the sector that received positive sentiment amid the Covid-19 outbreak is the Pharmaceutical Company Sector. The purpose of this study is to analyse the effect of earning per share, financial performance, and stock liquidity on stock returns during the Covid-19 pandemic (a case study on a pharmaceutical company listed on the Indonesia Stock Exchange). The method used in this study is quantitative. The source of data used in this study is secondary data. The sampling technique used in this research is the purposive sampling technique. This study indicates that return on equity has a significant effect on stock returns. Earnings per share and stock liquidity have no impact on stock returns.

查看原文本刊更多论文

COVID-19期间制药公司的股票收益

新冠肺炎疫情对印尼公司股价产生了重大影响，而在新冠肺炎疫情期间获得积极情绪的行业是制药公司行业。本研究的目的是分析Covid-19大流行期间每股收益、财务业绩和股票流动性对股票回报的影响(以印度尼西亚证券交易所上市的一家制药公司为例研究)。本研究采用的方法是定量的。本研究使用的数据来源为二手数据。本研究采用的抽样技术是目的性抽样技术。本研究表明，净资产收益率对股票收益有显著影响。每股收益和股票流动性对股票收益没有影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ajar-African Journal of Aids Research 医学-公共卫生、环境卫生与职业卫生

CiteScore

1.80

自引率

8.30%

发文量

审稿时长

>12 weeks

期刊介绍： African Journal of AIDS Research (AJAR) is a peer-reviewed research journal publishing papers that make an original contribution to the understanding of social dimensions of HIV/AIDS in African contexts. AJAR includes articles from, amongst others, the disciplines of sociology, demography, epidemiology, social geography, economics, psychology, anthropology, philosophy, health communication, media, cultural studies, public health, education, nursing science and social work. Papers relating to impact, care, prevention and social planning, as well as articles covering social theory and the history and politics of HIV/AIDS, will be considered for publication.